EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Effects of caffeine intake on depressive and anxiety symptoms: a systematic review and meta-analysis of randomized controlled trials

Ailing Zhang, Yudan Ni, Zhongyu Zhang, Jun Wang, Weiwei Chen, Furong Chang, Hengyu Cui, Changzheng Yuan, Dong Hang, Lin Li

Frontiers in Nutrition · 29.10.2026 · 13

DOI: 10.3389/fnut.2026.1950050 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Nutrition, online erschienen am 29.10.2026. Verfasst von Ailing Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Caffeine is one of the most widely consumed psychoactive dietary components worldwide. However, its effects on affective symptoms remain uncertain, with inconsistent findings regarding depressive and anxiety outcomes. This systematic review and meta-analysis aimed to evaluate the effects of quantified caffeine intake on affective symptoms based exclusively on randomized controlled trial (RCT) evidence.

Methods

The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement and was registered in the International Prospective Register of Systematic Reviews (PROSPERO; CRD42024564399). PubMed/MEDLINE, Embase, the Cochrane Library, Web of Science, CBM, VIP, CNKI, and Wanfang Data were searched from inception to May 16, 2026. Random-effects meta-analyses used restricted maximum likelihood estimation with Hartung–Knapp adjustment. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) and, where appropriate, 95% prediction intervals (PIs) were reported. Clinical coherence was examined according to exposure pattern and psychiatric status, and dose-stratified analyses were exploratory.

Results

Fifteen RCTs involving 668 participants contributing to the selected comparisons were included. For depressive symptoms, the broad pooled estimate did not show clear evidence of a difference between caffeine and control conditions [SMD = −0.49, 95% CI: (−1.33, 0.34); I 2 = 92.89%; 95% PI: (−2.87, 1.88)]. Anxiety scores were higher on average after caffeine exposure [SMD = 0.51, 95% CI: (0.12, 0.89); I 2 = 90.30%], although the 95% PI crossed the null (−0.95, 1.96). In acute non-psychiatric comparisons, pooled estimates were −0.15 [95% CI: (−2.12, 1.81)] for depressive symptoms and 0.38 [95% CI: (−0.02, 0.79)] for anxiety. Exploratory dose stratification showed higher anxiety scores in the >200 mg category [SMD = 0.97, 95% CI: (0.55, 1.39)] but not in the ≤200 mg category [SMD = −0.05, 95% CI: (−0.41, 0.30)]. Certainty of evidence was very low for both outcomes, and small-study effects were detected for anxiety.

Discussion

Randomized evidence does not support a uniform effect of caffeine across settings. The positive broad anxiety estimate should be interpreted cautiously because of substantial heterogeneity, a prediction interval spanning the null, and very-low-certainty evidence. Dose-category findings remain exploratory and do not establish a clinical threshold or continuous dose–response relationship. Systematic Review Registration https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=564399 , PROSPERO CRD42024564399.

Schlagwörter

Stichwörter der Autor:innen

anxiety symptomscaffeine intakedepressive symptomsdose stratificationmeta-analysisrandomized controlled trials

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Jingjiang College, Jiangsu University, Zhenjiang, China.
  • Health Management Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Department of Epidemiology, School of Public Health, Changzhou Medical Center, Gusu School, Nanjing Medical University, Nanjing, China.
  • Center of Clinical Big Data and Analytics of the Second Affiliated Hospital and School of Public Health, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Department of Social Services, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Zitieren

APA

Zhang, A., Ni, Y., Zhang, Z., Wang, J., Chen, W., Chang, F., Cui, H., Yuan, C., Hang, D., & Li, L. (2026). Effects of caffeine intake on depressive and anxiety symptoms: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1950050

Vancouver

Zhang A, Ni Y, Zhang Z, Wang J, Chen W, Chang F, et al. Effects of caffeine intake on depressive and anxiety symptoms: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1950050

BibTeX
@article{Zhang2026,
  author = {Zhang, Ailing and Ni, Yudan and Zhang, Zhongyu and Wang, Jun and Chen, Weiwei and Chang, Furong and Cui, Hengyu and Yuan, Changzheng and Hang, Dong and Li, Lin},
  title = {Effects of caffeine intake on depressive and anxiety symptoms: a systematic review and meta-analysis of randomized controlled trials},
  journal = {Frontiers in Nutrition},
  year = {2026},
  volume = {13},
  doi = {10.3389/fnut.2026.1950050}
}
Kostenlos starten →